Mark R. Fielden

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

Zhiguang Li, Weida Tong, Živana Težak et al. · Nature Biotechnology · 2010 · 915 citations · Full text

Life Sciences, Bioinformatics, Molecular Genetics +7

Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action

Brigitte Ganter, Stuart Tugendreich, Cecelia I. Pearson et al. · Journal of Biotechnology · 2005 · 287 citations

Pharmacy, Bioinformatics, Toxicology +16

Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro

Wenyue Hu, Claudio Sorrentino, Michael S. Denison et al. · Molecular Pharmacology · 2007 · 221 citations

Pharmacy, Pharmacology, Toxicology +17

A Gene Expression Biomarker Provides Early Prediction and Mechanistic Assessment of Hepatic Tumor Induction by Nongenotoxic Chemicals

Mark R. Fielden, Richard Brennan, Jeremy Gollub · Toxicological Sciences · 2007 · 206 citations

Pharmacy, Pharmacology, Toxicology +17

Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences

Yanni Sun, Darrell R. Boverhof, Lyle D. Burgoon et al. · Nucleic Acids Research · 2004 · 205 citations · Full text

Life Sciences, Genetics, Molecular Biology +13